Tengteng Yu
- Hematology top 5%
- Oncology top 10%
- Molecular Biology
- Immunology
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Kenneth C. AndersonYu‐Tzu TaiLijie XingShih‐Feng ChoLiang LinKenneth WenNikhil C. MunshiPhillip A. Hsieh
- Topics
- Multiple Myeloma Research and Treatments (31 papers)CAR-T cell therapy research (11 papers)Protein Degradation and Inhibitors (11 papers)
- Cited by
- HematologyOncologyImmunology
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Tengteng Yu
37 papers receiving 551 citations
Peers
Comparison fields: 5 of 45
- Hematology 340
- Oncology 330
- Molecular Biology 280
- Immunology 142
- Radiology, Nuclear Medicine and Imaging 123
Countries citing papers authored by Tengteng Yu
This map shows the geographic impact of Tengteng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tengteng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tengteng Yu more than expected).
Fields of papers citing papers by Tengteng Yu
This network shows the impact of papers produced by Tengteng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tengteng Yu. The network helps show where Tengteng Yu may publish in the future.
Co-authorship network of co-authors of Tengteng Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Tengteng Yu. A scholar is included among the top collaborators of Tengteng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tengteng Yu. Tengteng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 27 | |
| 11 | 22 | |
| 12 | 21 | |
| 13 | 64 | |
| 14 | 50 | |
| 15 | 10 | |
| 16 | 0 | |
| 17 | 66 | |
| 18 | 23 | |
| 19 | 2 | |
| 20 | 23 |
About Tengteng Yu
Tengteng Yu is a scholar working on Hematology, Oncology and Immunology, having authored 44 papers that have together received 555 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), CAR-T cell therapy research (11 papers) and Protein Degradation and Inhibitors (11 papers). The work is most often cited by research in Hematology (340 citations), Oncology (330 citations) and Immunology (142 citations). Tengteng Yu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Kenneth C. Anderson, Yu‐Tzu Tai, Lijie Xing, Shih‐Feng Cho, Liang Lin, Kenneth Wen, Nikhil C. Munshi, Phillip A. Hsieh, Yuyin Li and Hailin Chen. Their work appears in journals such as Blood, Clinical Cancer Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.